Inotiv Stock Forecast, Price & News

-1.88 (-6.55 %)
(As of 05/11/2021 12:00 AM ET)
Today's Range
50-Day Range N/A
52-Week Range
Volume98,806 shs
Average Volume114,582 shs
Market Capitalization$381.68 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NOTV News and Ratings via Email

Sign-up to receive the latest news and ratings for Inotiv and its competitors with MarketBeat's FREE daily newsletter.

About Inotiv

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.


See More Headlines

Industry, Sector and Symbol

Industry Diagnostics & Research
Current SymbolNASDAQ:NOTV
Phone765 463 4527
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Market Cap$381.68 million
Next Earnings Date8/13/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

0.34 out of 5 stars

Medical Sector

1782nd out of 2,045 stocks

Diagnostics & Research Industry

13th out of 15 stocks

Analyst Opinion: 0.0Community Rank: 1.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Inotiv (NASDAQ:NOTV) Frequently Asked Questions

What stocks does MarketBeat like better than Inotiv?

Wall Street analysts have given Inotiv a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Inotiv wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Inotiv's next earnings date?

Inotiv is scheduled to release its next quarterly earnings announcement on Friday, August 13th 2021.
View our earnings forecast for Inotiv

What guidance has Inotiv issued on next quarter's earnings?

Inotiv updated its second quarter 2021 earnings guidance on Tuesday, May, 4th. The company provided EPS guidance of - for the period. The company issued revenue guidance of $18.50 million-$18.80 million, compared to the consensus revenue estimate of $16.61 million.

Who are Inotiv's key executives?

Inotiv's management team includes the following people:
  • Mr. Robert W. Leasure Jr., Pres, CEO & Director (Age 61, Pay $529.23k)
  • Dr. John E. Sagartz D.V.M., DiplomateACVP, DVM, Ph.D., Chief Strategy Officer & Director (Age 56, Pay $289.82k)
  • Mr. Joseph Earl Flynn, Chief Commercial Officer (Age 55, Pay $310k)
  • Dr. Peter T. Kissinger, Founder, Chairman Emeritus & Scientific Advisor (Age 76)
  • Ms. Beth A. Taylor C.P.A., CFO, VP of Fin. & Sec. (Age 56)
  • Mr. John Gregory Beattie, Chief Operating Officer
  • Mr. William D. Pitchford, Chief HR Officer (Age 66)
  • Mr. Philip A. Downing, Sr. VP of Nonclinical Services (Age 51)
  • Dr. Michael A. Baim Ph.D., Sr. VP of Analytical Operations (Age 63)
  • Dr. J. Scott Daniels, Sr. VP of DMPK

Who are some of Inotiv's key competitors?

What is Inotiv's stock symbol?

Inotiv trades on the NASDAQ under the ticker symbol "NOTV."

Who are Inotiv's major shareholders?

Inotiv's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include EAM Investors LLC (0.50%), Russell Investments Group Ltd. (0.31%), BlackRock Inc. (0.24%), Versant Capital Management Inc (0.17%), Acadian Asset Management LLC (0.12%) and Legacy Wealth Planning LLC (0.07%).

Which institutional investors are buying Inotiv stock?

NOTV stock was bought by a variety of institutional investors in the last quarter, including EAM Investors LLC, Russell Investments Group Ltd., BlackRock Inc., Versant Capital Management Inc, Acadian Asset Management LLC, Legacy Wealth Planning LLC, and Dorsey Wright & Associates.

How do I buy shares of Inotiv?

Shares of NOTV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inotiv's stock price today?

One share of NOTV stock can currently be purchased for approximately $26.83.

How much money does Inotiv make?

Inotiv has a market capitalization of $381.68 million.

How many employees does Inotiv have?

Inotiv employs 397 workers across the globe.

What is Inotiv's official website?

The official website for Inotiv is

How can I contact Inotiv?

The company can be reached via phone at 765 463 4527.

This page was last updated on 5/12/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.